Sanofi announced an equity investment of $180 million and a new strategic collaboration with Owkin comprised of discovery and development programmes in four exclusive types of cancer, with a total payment of $90 million for three years plus additional research milestone-based payments. Owkin, an artificial intelligence (AI) and precision medicine company, builds best-in-class predictive biomedical AI models and robust data sets.
- Read more about Sanofi invests 180 million dollar equity in Owkins artificial intelligence and federated learning to advance oncology pipeline
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/sanofi-invests-180-million-dollar-equity-in-owkins-artificial-intelligence-and-federated-learning-to-advance-oncology-pipeline
No comments:
Post a Comment